The Senior Officer of Lexington Biosciences (Other OTC: LXGTF) is Buying Shares

Today, the Senior Officer of Lexington Biosciences (LXGTFResearch Report), Nicholas John Furber, bought shares of LXGTF for $82.9K.

See today’s analyst top recommended stocks >>

Currently, Lexington Biosciences has an average volume of . The company has a one-year high of $0.40 and a one-year low of $0.01.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Lexington Biosciences Inc is a Canada based company that develops and commercializes non-invasive diagnostic products for cardiovascular health that integrate with centralized data analysis applications to provide medical professionals and consumers key insights into their critical health metrics.